Patent offices

U.S. Patent & Trademark Office Issues Patent to ComplianceMate® for Innovative Food Safety Management System

Retrieved on:

Friday, June 4, 2021

Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, Food safety, Food science, Product safety, Patent, United States Patent and Trademark Office

LAWRENCEVILLE, Ga., June 3, 2021 /PRNewswire/ --CM Systems LLC, (ComplianceMate), a leader in Food Safety Technology and Automation, announced the United States Patent and Trademark Office issued U.S. Patent No.

Key Points:

LAWRENCEVILLE, Ga., June 3, 2021 /PRNewswire/ --CM Systems LLC, (ComplianceMate), a leader in Food Safety Technology and Automation, announced the United States Patent and Trademark Office issued U.S. Patent No.
11,004,020 to ComplianceMatefor its Digital Food Safety Management System.
9,811,788 to ComplianceMate in 2017 for the various embodiments of a food safety management system, including a web portal for management and reporting, and a handheld computing device for checklist completion.
The granting of this patent underscores our commitment to the industry and enhances our position as a leader in the Food Service marketplace," said Steve Getraer,President of ComplianceMate.

Soundbite Medical Solutions Announces Issuance of a Third U.S. Patent Expanding Coverage of its Core Technology

Retrieved on:

Tuesday, May 18, 2021

Health, Medical devices, Cardiology, Intellectual property law, Patent offices, Patent and Trademark Office, United States patent law

b"Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office (USPTO) has issued US patent No.

Key Points:

b"Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office (USPTO) has issued US patent No.
11,000,880, entitled \xe2\x80\x9cMechanical Waveguide Provided With A Marker Thereon\xe2\x80\x9d.\nThe patent is directed to a proprietary waveguide specially designed for the transmission of shock waves used in the treatment of cardiovascular disease.
A fourth US patent has recently been allowed.
The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward looking statements.

Exacta Awarded Historic Horse Racing Patent On Using Multiple Past Events To Generate A Wagering Outcome

Retrieved on:

Tuesday, May 11, 2021

Intellectual property law, Patent offices, Intellectual property organizations, Monopoly, Patent, United States Patent and Trademark Office

b'BOYNTON BEACH, Fla., May 11, 2021 /PRNewswire/ --Exacta Systems announced today that it has been awarded a patent on its techniques for using multiple events that occurred in the past to generate a wagering outcome.

Key Points:

b'BOYNTON BEACH, Fla., May 11, 2021 /PRNewswire/ --Exacta Systems announced today that it has been awarded a patent on its techniques for using multiple events that occurred in the past to generate a wagering outcome.
The United States Patent and Trademark Office issued the patent to Exacta for its "System and Method of Wagering on a Plurality of Events" on May 4, 2021.\n"We are very excited that the U.S. Patent Office has granted our patent on using a plurality of events to generate a wagering outcome," commented Exacta Systems CEO Jeremy Stein.
"Our innovation opened up the possibilities to create fun, engaging, and competitive products for the historical horse racing industry.
We are proud that our innovation encompasses the way historical horse racing systems currently operate.

Palatin Announces U.S. Patent Term Extension for Vyleesi® (bremelanotide injection)

Retrieved on:

Tuesday, May 4, 2021

Intellectual property law, Patent law, Term of patent in the United States, United States patent law, Intellectual property organizations, Term of patent, International Searching and Preliminary Examining Authorities, Patent offices, Bremelanotide, Drug Price Competition and Patent Term Restoration Act, United States Patent and Trademark Office, Patent

For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.

Key Points:

For more information on Vyleesi, go to www.vyleesi.com .\nThe patent term extension is pursuant to the Drug Price Competition and Patent Term Restoration Act of 1984, commonly called the Hatch-Waxman Amendments, which permits an extension of the term of one patent for a maximum period of five years as compensation for patent term lost during drug development and the FDA regulatory review process.
An interim extension for a period of one year from the original expiration date of both patents of June 25, 2020, was granted by the USPTO in May 2020.
In the Notices of Final Determination issued by the USPTO, the maximum allowable five-year extension was granted.\nPalatin has filed an Election to extend the patent term of U.S. patent 6,794,489.
Palatin is not responsible for updating for events that occur after the date of this press release.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/palatin-announces-us-patent-term...\n'

Lobe Sciences Announces Filing of PCT Application

Retrieved on:

Thursday, April 29, 2021

Countries, Government, Foreign relations, United States patent law, Patent law, International Searching and Preliminary Examining Authorities, Patent offices, Patent application, Provisional application, Patent, United States Patent and Trademark Office, Post-traumatic stress disorder

PCT filing further strengthens the Company's intellectual property portfolio

Key Points:

"\nThe Company\'s PCT filing includes details that were previously submitted in three separate US provisional patent applications filed with the U.S. Patent and Trademark Office ("USPTO").
The PCT is an international patent law treaty which provides a unified procedures for filing patent application to protection inventions in each of its member states.
By filing one international patent application under the PCT, the Company can simultaneously seek protection for an invention in 153 countries.\nThe PCT application relates to methods for treating or alleviating symptoms of mild traumatic brain injury ("mTBI"), post-traumatic stress disorder ("PTSD") and mTBI with PTSD via administration of a psychedelic agent in combination with N-acetylcysteine ("NAC").
Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect.

Minesto enhances and extends its IP protection with approved patent

Retrieved on:

Friday, April 16, 2021

Monopoly, Patent, Patent law, Patent offices

b'STOCKHOLM, April 16, 2021 /PRNewswire/ -- Leading marine energy developer Minesto reinforces its already extensive patent portfolio covering the company\'s unique ocean energy technology.

Key Points:

b'STOCKHOLM, April 16, 2021 /PRNewswire/ -- Leading marine energy developer Minesto reinforces its already extensive patent portfolio covering the company\'s unique ocean energy technology.
Minesto has been granted a new patent by which the company extends the protection of its core technology.\nThe approved patent concerns a technical innovation that Minesto developed and has verified in its tidal energy project in the Faroe Islands.
Our IP strategy is as simple as it is effective: we systematically extend the protection of the core technology by `shielding\' the main patent with complementary patents related to supporting subsystems and offshore processes.
Through this, we create significant commercial value for Minesto and its shareholders", said Dr Martin Edlund, CEO of Minesto.\nThe approval of the new patent means that the patent protection surrounding Minesto\'s unique ocean energy technology called Deep Green now consists of eleven patent families.

GTX Reports 2020 Financial Summary

Retrieved on:

Monday, April 5, 2021

Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, GTX, Patent and Trademark Office, Global Positioning System

LOS ANGELES CALIFORNIA, April 05, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (GTX or the Company), a pioneer in the field of location based wearable GPS human and asset tracking systems and a supplier of Health and Safety personal protective medical equipment, today announced a summary for the year ended December 31, 2020.

Key Points:

LOS ANGELES CALIFORNIA, April 05, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (GTX or the Company), a pioneer in the field of location based wearable GPS human and asset tracking systems and a supplier of Health and Safety personal protective medical equipment, today announced a summary for the year ended December 31, 2020.
In these unprecedented times we want to first and foremost extend our appreciation and gratitude to every GTX stake holder from our employees, vendors, customers, advisors, and shareholders that helped GTX navigate and expand throughout 2020.
2020 was probably our most transformative year since we launched our GPS SmartSoles.
During the third quarter of 2020, GTX was issued a new patent by the United States Patent and Trademark Office (USPTO), U.S Patent No.

Farmobile Awarded U.S. Patent for Farm Data Collection and Exchange System

Retrieved on:

Thursday, April 1, 2021

Farmobile LLC , Agricultures Independent Data Company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Key Points:

Farmobile LLC , Agricultures Independent Data Company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
10,963,825 , entitled Farming Data Collection and Exchange System.
The patent is directed to a cloud-based farming data collection and exchange system capable of capturing, processing and sharing machine-generated data while being used for farming operations, such as fertilizing, planting, spraying or harvesting crops on a field.
The patented technology enables real-time collection, tracking, monitoring, sharing and monetizing of critically important farming operation data.

Life Spine Announces Issuance of 200th Patent

Retrieved on:

Wednesday, March 31, 2021

Biotechnology, Surgery, Medical devices, Hospitals, Health, Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, Monopoly, Patent, United States Patent and Trademark Office, Spine, United States patent law

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received notice of issuance from the U.S. Patent and Trademark Office (USPTO) regarding U.S. Patent No.

Key Points:

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received notice of issuance from the U.S. Patent and Trademark Office (USPTO) regarding U.S. Patent No.
10,973,553, which signifies Life Spines 200th patent to date.
With our 200th patent granted, Life Spine has one of the highest patent outputs per employee in the industry and this rich IP portfolio is a key driver to our success, said Michael Butler, Life Spine President and CEO.
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.

Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)

Retrieved on:

Wednesday, March 24, 2021

Intellectual property law, Intangible assets, United States trademark law, Patent offices, United States Patent and Trademark Office, Trademark, Patent and Trademark Office, Patent, United States patent law

Lastly the Company is in the process of registering Trademark(s) for its Tauri-Pet product line, with both the United States Patent & Trademark Office (USPTO) and the European Union Intellectual Property Office (EUIPO).

Key Points:

Lastly the Company is in the process of registering Trademark(s) for its Tauri-Pet product line, with both the United States Patent & Trademark Office (USPTO) and the European Union Intellectual Property Office (EUIPO).
Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative.
On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum.
Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances.